Concepedia

Katharina Erb‐Zohar

KE

Statistics

Publications

5

Citations

137

H-Index

5

Active since

2017

Affiliations

AiCuris (Germany)(Current)

Klinikum Hanau

Schott (Germany)

MSD (Netherlands)

Katharina Erb‐Zohar is an author at AiCuris (Germany) specializing in clinical pharmacology, antiviral pharmacology, and antiviral therapy.

Publications per year

2017–2021

5

Publications

5

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

Dirk Kropeit, Jürgen Scheuenpflug, Katharina Erb‐Zohar et al. · British Journal of Clinical Pharmacology · 2017 · 37 citations · Full text

, , +17

Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial

Katharina Erb‐Zohar, Dirk Kropeit, Jürgen Scheuenpflug et al. · Clinical and Translational Science · 2017 · 31 citations · Full text

, , +15

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

Dirk Kropeit, David McCormick, Katharina Erb‐Zohar et al. · British Journal of Clinical Pharmacology · 2017 · 31 citations · Full text

, , +17

How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum

Jens Rengelshausen, Kerstin Breithaupt-Groegler, Frank Donath et al. · Therapeutic Innovation & Regulatory Science · 2021 · 26 citations · Full text

, , +14

Pharmacokinetics and Safety of Letermovir and Midazolam Coadministration in Healthy Subjects

Dirk Kropeit, David McCormick, Katharina Erb‐Zohar et al. · Clinical Pharmacology in Drug Development · 2021 · 12 citations

, , +17

1–5 of 5